Author

K. P. Williams

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. B. Rokes· 1 shared A. Sinha· 1 shared B. Bowman· 1 shared B. Weissman· 1 shared B. Y. Lau· 1 shared C. Huang· 1 shared C. M. Mageeney· 1 shared C. Paiboonrungruang· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. B. Rokes

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyRedox BiologyPeer-reviewedNov 1, 2023

Small Molecule Screen Identifies Pyrimethamine as an Inhibitor of NRF2-driven Esophageal Hyperplasia

C. Paiboonrungruang, Z. Xiong, D. Lamson…·X. Chen

This study identifies pyrimethamine as an NRF2 inhibitor that suppresses esophageal hyperplasia in a mouse model and shows potential for clinical use in NRF2-high ESCC.

DOI 10.1016/j.redox.2023.102901

mousebulk RNA-seq

MicrobiologybioRxivPreprintJan 26, 2020

Computationally-guided technology platform for on-demand production of diversified therapeutic phage cocktails

C. M. Mageeney, A. Sinha, R. A. Mosesso…·K. P. Williams

This paper develops a computational platform to produce customized phage cocktails targeting antibiotic-resistant bacteria, demonstrating efficacy against Pseudomonas aeruginosa.

DOI 10.1101/2020.01.26.918771

bacteria (other)metagenomics